EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2014-169-173
Abstract
Objective. To study the content of the suppressor population of regulatory T cells (Treg) according to the expression of CD4, CD25, CD127 molecules, as well as the expression of two functional molecules (CTLA-4 and CD39) in patients with rheumatoid arthritis (RA).
Material and methods. 16 samples of peripheral blood of RA patients and 10 blood samples of healthy donors were analyzed. All patients received disease-modifying anti-rheumatic drugs. The expression level of all studied molecules was assessed by flow cytofluorometry.
Results. The content of T-helpers in peripheral blood of RA patients was 36.3 ± 7.1% of the total number of lympho- cytes and was lower than that in the control (43.8 ± 6.2%, p<0.05). The number of activated CD4+CD25+ T cells in these patients increased twofold (RA 23.7 ± 9.8%, control 11.1 ± 2.0% of the number of CD4+ T cells, p<0.05). The relative amount of CD4+CD25high (RA 2.7 ± 1.0%, control 1.5 ± 0.8%) and CD4+CD25highCD127low/- (RA 2.5 ± 1.0%, control 1.6 ± 0.9% of CD4+ T cells) Treg cells in RA patients was significantly higher than that in healthy individuals (p<0.05). The expression of the CTLA-4 negative regulatory molecule and CD39 ectonucleotidase by Treg cells of RA patients did not differ from the control.
Conclusion. The study demonstrated that RA is characterized by an increased content of Treg cells of CD4+CD25high and CD4+CD25highCD127low phenotypes rather than CD4+CD25+CD127low, as well as by the control-like expression of CTLA-4 and CD39 functional molecules by Treg cells.
About the Authors
G. A. Zhulai
Institute of Biology, Karelian Research Center of the Russian Academy of Sciences, Petrozavodsk, Russia
Russian Federation
Russian Federation
E. K. Oleinik
Institute of Biology, Karelian Research Center of the Russian Academy of Sciences, Petrozavodsk, Russia
Russian Federation
Russian Federation
O. Yu. Barysheva
Petrozavodsk State University, Petrozavodsk, Russia
Russian Federation
Russian Federation
A. V. Churov
Institute of Biology, Karelian Research Center of the Russian Academy of Sciences, Petrozavodsk, Russia
Russian Federation
Russian Federation
V. M. Oleinik
Institute of Biology, Karelian Research Center of the Russian Academy of Sciences, Petrozavodsk, Russia
Russian Federation
Russian Federation
P. N. Kravchenko
Institute of Biology, Karelian Research Center of the Russian Academy of Sciences, Petrozavodsk, Russia
Russian Federation
Russian Federation
A. A. Kuchin
Petrozavodsk State University, Petrozavodsk, Russia
Russian Federation
Russian Federation
References
1. Shevach EM. Mechanisms of Foxp3+ T perulatory cell-mediated suppression. Immunity. 2009 May;30(5):636–45.
2. Насонов ЕЛ, Насонова ВА, редакторы. Ревматология: Национальное руководство. Москва: ГЭОТАР-Медиа; 2008. [Nasonov EL, Nasonova VA, editors. Revmatologiya: Natsional'noe rukovodstvo [Rheumatology: National management]. Moscow: GEOTAR-Media; 2008.
3. Morgan ME, Sutmuller RP, Witteveen HJ, et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 2003 May;48(5):1452–60. DOI: http://dx.doi.org/10.1002/art.11063.
4. Mö ttö nen M, Heikkinen J, Mustonen L, et al. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol. 2005 May;140(2):360–7. DOI: http://dx.doi.org/10.1111/j.1365- 2249.2005.02754.x.
5. Han GM, O’Neil-Andersen NJ, Zurier RB, Lawrence DA. CD4+CD25high T cell numbers are enriched in the peripheral blowod of patients with rheumatoid arthritis. Cell Immunol. 2008 May-Jun;253(1–2):92–101. DOI: http://dx.doi.org/10.1016/j.cel- limm.2008.05.007.
6. Kim JR, Chae JN, Kim SH, Ha JS. Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease. J Korean Med Sci. 2012 Sep;27(9):1009–13. DOI: http://dx.doi.org/10.3346/jkms.2012.27.9.1009.
7. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006 Jul 10;203(7):1693–700. DOI: http://dx.doi.org/10.1084/jem.20060468.
8. Hartigan-O’Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T cells express lowwer levels of the IL-7 receptor alpha chain (CD127) allowwing consistent identification and sorting of live cells. J Immunol Methods. 2007 Jan 30;319(1–2):41–52. DOI: http://dx.doi.org/10.1016/j.jim.2006.10.008.
9. Aerts NE, Dombrecht EJ, Ebo DG, et al. Activated T cells com-
10. plicate the identification of regulatory T cells in rheumatoid arthritis. Cell Immunol. 2008 Feb;251(2):109–15. DOI: http://dx.doi.org/10.1016/j.cellimm.2008.04.008.
11. Kawashighri SY, Kawakami A, Okada A, et al. CD4+CD25highCD127low/-Treg cell frequency from peripheral blowod correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol. 2011 Dec;38(12):2517–21. DOI: http://dx.doi.org/10.3899/jrheum.110283.
12. Flowres-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA. 2008 Dec 9;105(49):19396–401. DOI: http://dx.doi.org/10.1073/pnas.0806855105.
13. Hasko G, Linden J, Cronstein B, Pacher P. Adenosin receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008 Sep;7(9):759–70. DOI: http://dx.doi.org/10.1038/nrd2638.
14. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation cat- alyzed by CD39 and CD73 expressed on regulatory T cells medi- ates immune suppression. J Exp Med. 2007 Jun 11;204(6):1257–65. DOI: http://dx.doi.org/10.1084/jem.20062512.
15. Dunham RM, Cervasi B, Brenchley JM, et al. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol. 2008 Apr 15;180(8):5582–92.
16. Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010 Dec;10(12):849–59. DOI: http://dx.doi.org/10.1038/nri2889.
17. Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. 2008 Aug;224:166–82. DOI: http://dx.doi.org/10.1111/j.1600- 065X.2008.00662.x.
Review
For citations:
Zhulai G.A., Oleinik E.K., Barysheva O.Yu., Churov A.V., Oleinik V.M., Kravchenko P.N., Kuchin A.A. EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2014;52(2):169-173. (In Russ.) https://doi.org/10.14412/1995-4484-2014-169-173
Views:
1041
Email this article 